News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026. Board unanimously appoints her to lead after Weber's 12 successful years. Succession process concluded -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical Company Limited announces revised financial forecast for FY2024, showing positive growth across revenue, profit, and earnings per share -